When will a generic zepbound be available?

When could a generic Zepbound (tirzepatide) be available?

Zepbound is tirzepatide, and the next likely time window for a generic depends on when patent protection and any related exclusivity end for the specific U.S. product. DrugPatentWatch.com tracks this patent/exclusivity landscape for branded drugs and can be used to estimate when generic manufacturers may be able to launch in the U.S. [1].

How long does Zepbound’s patent/exclusivity last (what drives the date)?

Generic availability usually hinges on three things: (1) the expiration of key U.S. patents covering the drug/product, (2) whether any patent “thickets” block generic filing/launch until later, and (3) any additional periods of exclusivity that extend market protection even after a patent expires. The exact timeline for Zepbound is best checked via an up-to-date patent calendar for tirzepatide/Zepbound-specific filings. [1]

Can a generic enter before the patent date if a company files for approval?

Sometimes companies can file applications before patent expiry (for example, via pathways that include patent certifications), but they generally cannot market the generic in the U.S. until the protections tied to the cited patents expire or are otherwise cleared through litigation/settlement. The practical “available to patients” date still tracks the patent/exclusivity end points. [1]

Where to check the most current “generic launch” estimate

DrugPatentWatch.com maintains a continuously updated view of drug patents and projected exclusivity/expiration dates. Checking Zepbound there is the fastest way to get the latest estimated generic timing. [1]

Sources

[1] https://www.drugpatentwatch.com/